Author
Vana Papaevangelou
Also Known As
V Papaevangelou, V. Papaevangelou, VANA PAPAEVANGELOU, Vana G Papaevangelou, Vana G. Papaevangelou, Vana Papaevangelou
35
Publications
764
Citations
13
H-Index
32
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 6 | 6 | 125 |
2 | Immunology | 3 | 3 | 76 |
3 | Health Sciences | 1 | 1 | 23 |
4 | Allergy | 1 | 1 | 10 |
5 | Epidemiology | 1 | 1 | 13 |
Vana Papaevangelou
×
12
Publications
306
Citations
10
H-Index
| Year | Citations | |
|---|---|---|
1990 | 56 | |
2005 | 43 | |
2016 | 38 | |
1994 | 32 | |
2009 | 25 | |
2009 | 23 | |
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial L. Hill, Michelle Clements, M. Turner, The Lancet Child & Adolescent Health Health SciencesAntimicrobial StewardshipAntibioticsPhase 2BPediatric Intensive Care | 2021 | 23 |
2013 | 20 | |
2008 | 13 | |
1994 | 13 |
Page 1
Page 1